StockWatch
·

EMMESSAR BIOTECH & NUTRITION LTD. Q3 FY25 Results

EMMESSAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue0.1071.8%
Total Income0.5337.6%
Expenditure0.409.9%
PBT0.1368.0%
Net Profit0.0293.9%
OPM
NPM-7.92%40.74pp
EPS0.0394.6%
View full financials

Informational and educational content only. Not investment advice.